Search:
 

Global results

Since its creation in 2000, the GAVI Alliance has helped to increase significantly the number of children worldwide who have access to immunisation.

WHO estimates and projections for the period 2000-2008 show GAVI support has:

  • prevented a cumulative 3.4 million future deaths. (This was estimated to be 2.8 million for the period 2000-2007);
  • protected a cumulative 50.9 million children with basic vaccines against DTP3 (diphtheria, tetanus, and pertussis.) (This was estimated to be 37.9 million for the period 2000-2007);
  • protected a cumulative 213 million children with new and underused vaccines (This was estimated to be 172 million for the period 2000-2007);

    This figure of 213 million represents the total number of children reached with any GAVI-supported vaccine, corrected so that children receiving multiple vaccines are not double-counted.

    The breakdown of new and underused vaccine coverage show:

    • a cumulative 192.2 million children have been immunised against hepatitis B (This was estimated to be 155.7 million for the period 2000-2007);

    • a cumulative 41.7 million children have been immunised against Haemophilus influenzae type b (Hib) (This was estimated to be 28.2 million for the period 2000- 2007);

    • a cumulative 35.6 million children have been immunised against yellow fever (This was estimated to be 26.3 million for the period 2000-2007).

    Since the GAVI Alliance inception, spending on routine immunisation in GAVI implementing countries has risen from all sources.

    SOURCES FOR DATA: WHO-UNICEF coverage estimates for 1980-2007, as at August 2008, WHO ICE-T coverage projections for 2008-2010, as at September 2008, World Population Prospects, the 2006 revision. New York, United Nations, 2007, Department of Immunization, Vaccines and Biologicals, projection for year 2008.